Back to search
Hyper IgD Syndrome
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Hyper IgD Syndrome trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Hyper IgD Syndrome trials you may qualify forThe objective of this extension protocol is to collect safety data (serious and non-serious adverse events) and to provide continuous canakinumab to patients in…
Participants wanted for study of mevalonate kinase deficiency (MKD), mevalonic aciduria, or hyperimmunoglobulinemia with periodic fever syndrome (HIDS). Patien…
The primary objective of this study was to evaluate safety and tolerability of ACZ885 in this extension study. This extension study offered the opportunity for…